West to Highlight Industry Leadership in Packaging and Containment at CPHI Worldwide
PR Newswire•05/10/2026•06:00 ET
0
Key Highlights
- ➤West (WST) will showcase SelfDose® patient-controlled injector at CPHI Worldwide
- ➤West’s Synchrony® S1 prefillable syringe system powers the SelfDose® injector
- ➤West generated $3.07 billion in fiscal 2025 net sales
- ➤West delivers over 41 billion components and devices annually
Expert Statements
Shane Campbell, Senior Vice President and Chief Proprietary Segment Officer at West
“For over a century, West has partnered with the world's leading pharmaceutical companies to help address complex drug packaging and delivery challenges.”
Shane Campbell, Senior Vice President and Chief Proprietary Segment Officer at West
“At this year's CPHI, we are proud to showcase our SelfDose® patient-controlled injector, powered by the West Synchrony® S1 prefillable syringe system, which demonstrates how West is advancing patient-centered drug delivery through thoughtful design and an integrated delivery experience.”
West to Highlight Industry Leadership in Packaging and Containment at CPHI Worldwide PR Newswire
EXTON, Pa., Oct. 5, 2026 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced its participation in CPHI Worldwide in Milan, Italy, where it will highlight its leadership and expertise in addressing industry challenges.
Get started
Create a free account to read the full story.